Quest Diagnostics Inc vs Remitly Global Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Remitly Global Inc trades at $23.73 (market cap $4.97B). The key difference: Quest Diagnostics Inc is far larger — about 5.3× Remitly Global Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Remitly Global Inc pays none. Which is the better fit depends on your goals.
| DGX | RELY | |
|---|---|---|
Market Cap | $26.21B | $4.97B |
Sector | Health | Technology |
52-Week High | $238.50 | $25.93 |
52-Week Low | $173.49 | $12.20 |
Enterprise Value | $31.97B | $4.33B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →